Inventor · disambiguated record
Martin James Drysdale
Also filed as: DRYSDALE MARTIN · DRYSDALE MARTIN J · DRYSDALE MARTIN JAMES · SHEARER BARRY GEORGE
22 granted patents·14 pending applications·156 citations·filing 1995–2022
95Inventor score
Files withVERNALIS R&D LTD12VERNALIS CAMBRIDGE LTD8DRYSDALE MARTIN JAMES5NEOPHORE LTD3SMITHKLINE BEECHAM CORP2
Top patents by PatentIndex Score
36 records- 0186US8507480B2Isoxazole compounds as inhibitors of heat shock proteinsDRYSDALE MARTIN JAMES·Filed 2010·Granted Aug 13, 2013·8 cites·30 claims
- 0286US7612201B2Pyrazole compoundsVERNALIS CAMBRIDGE LTD·Filed 2003·Granted Nov 3, 2009·31 cites·7 claims
- 0384US8450310B2Isoxazole compounds as inhibitors of heat shock proteinsDRYSDALE MARTIN JAMES·Filed 2012·Granted May 28, 2013·6 cites·29 claims
- 0482US10413550B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2017·Granted Sep 17, 2019·2 cites·28 claims
- 0582US7632855B2Pyrazole compounds as HSP90 inhibitors for the treatment of cancerVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Dec 15, 2009·26 cites·20 claims
- 0680US9718793B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2013·Granted Aug 1, 2017·3 cites·29 claims
- 0780US7247734B23,4-diarylpyrazoles and their use in the therapy of cancerINST OF CANCER RES OF ROYAL CA·Filed 2002·Granted Jul 24, 2007·19 cites·20 claims
- 0878US5889056AEnzyme inhibitorsGLAXO WELLCOME INC·Filed 1995·Granted Mar 30, 1999·18 cites·9 claims
- 0977US7705027B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Apr 27, 2010·7 cites·34 claims
- 1076US11234987B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2019·Granted Feb 1, 2022·0 cites·29 claims
- 1174US7820658B2Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitorsVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Oct 26, 2010·9 cites·23 claims
- 1273US6620848B2Nitric oxide synthase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 16, 2003·7 cites·15 claims
- 1368US8916591B2Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activitySTOKES STEPHEN·Filed 2009·Granted Dec 23, 2014·2 cites·17 claims
- 1468US8642594B2Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitorsDYMOCK BRIAN WILLIAM·Filed 2010·Granted Feb 4, 2014·3 cites·15 claims
- 1568US7728016B2Substituted 5-membered ring compounds and their useVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Jun 1, 2010·4 cites·6 claims
- 1667US7803831B23-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancerVERNALIS CAMBRIDGE LTD·Filed 2003·Granted Sep 28, 2010·4 cites·18 claims
- 1764US2020361905A1Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory ActivityVERNALIS R&D LTD·Filed 2020·Application pending·0 cites
- 1862US8163747B2Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these formsDRYSDALE MARTIN JAMES·Filed 2008·Granted Apr 24, 2012·0 cites·17 claims
- 1959US10696652B2Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activityVERNALIS R&D LTD·Filed 2018·Granted Jun 30, 2020·0 cites·16 claims
- 2059US9604975B2Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activityVERNALIS R&D LTD·Filed 2014·Granted Mar 28, 2017·0 cites·14 claims
- 2156US8487095B2Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these formsDRYSDALE MARTIN JAMES·Filed 2012·Granted Jul 16, 2013·0 cites·3 claims
- 2255US2024425453A1Isoindolines as pms2 inhibitorsNEOPHORE LTD·Filed 2022·Application pending·0 cites
- 2355US2024425483A1Indolines as protac compoundsNEOPHORE LTD·Filed 2022·Application pending·0 cites
- 2454US2017298043A1Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory ActivityVERNALIS R&D LTD·Filed 2017·Application pending·0 cites
- 2553US2024293392A1Inhibitor compoundsNEOPHORE LTD·Filed 2022·Application pending·0 cites
- 2652US2013296556A1Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic Acid Ethylamide and Formulations Comprising These FormsDRYSDALE MARTIN JAMES·Filed 2013·Application pending·0 cites
- 2750US2007213328A1Pyridothiophene CompoundsVERNALIS CAMBRIDGE LTD·Filed 2004·Application pending·0 cites
- 2848US6369272B1Nitric oxide synthase inhibitorsGLAXOSMITHKLINE·Filed 1998·Granted Apr 9, 2002·4 cites·9 claims
- 2947US2009181989A1Purine Compunds as HSP90 Protein Inhibitors for the Treatment of CancerVERNALIS R&D LTD·Filed 2009·Application pending·0 cites
- 3046US2009054421A1Pyrimidothiophene Compounds Having HSP90 Inhibitory ActivityVERNALIS R&D LTD·Filed 2006·Application pending·0 cites
- 3145US2010010037A11h-pyrrolo[2,3-b]pyridine derivatives useful as hsp90 inhibitorsVERNALIS R&D LTD·Filed 2007·Application pending·0 cites
- 3242US2011034457A1Pyridothiophene CompoundsVERNALIS CAMBRIDGE LTD·Filed 2010·Application pending·0 cites
- 3342US2009163490A1Pyrrolopyrimidine Derivatives Used As HSP90 InhibitorsVERNALIS R&D LTD·Filed 2007·Application pending·0 cites
- 3438USRE39576EEnzyme inhibitorsSMITHKLINE BEECHAM CORP·Filed 1995·Granted Apr 17, 2007·3 cites·9 claims
- 3538US2009069336A1Pyrimidothiophene compoundsBARRIL-ALONSO XAVIER·Filed 2005·Application pending·0 cites
- 3634US2009131470A1Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disordersVERNALIS R&D LTD·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →